Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

January 21, 2021

Primary Completion Date

February 2, 2027

Study Completion Date

February 2, 2027

Conditions
Lung Non-Small Cell Carcinoma
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of blood, saliva, stool, and bronchoalveolar lavage samples

PROCEDURE

Bronchoscopy with Bronchoalveolar Lavage

Undergo bronchoscopy with BAL

OTHER

Chemoradiotherapy

Undergo concurrent chemoradiation per standard of care

PROCEDURE

Computed Tomography

Undergo computed tomography scan

OTHER

Diagnostic Laboratory Biomarker Analysis

Correlative studies

DRUG

Immune Checkpoint Inhibitor

Receive CPI per standard of care

PROCEDURE

Nasal Wash and Collection

Undergo nasal wash

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

PROCEDURE

Spirometry

Under lung spirometry tests

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER